Starpharm - A turnaround pharma stock

currently trading at small fraction of ipo price.

chinsoonyuen wrote: currently trading at small fraction of ipo price.

Soon Yuen, IPO price was 35c with 55m placement shareand no share dilution since IPO. Part of the IPO money raised was used to buy 60% stake in Beida Shijia. If it can luanch TCM drugs to treat Diabetes, Hepatitis or Rheumatics, fraction may become multiple. haha.

---

Beida Shijia's research pipeline shows excellent potential. It currently has 15 TCM-formulated prescription drugs in various stages of development, holding great market potential in addressing a wide spectrum of medical needs. These include products for the treatments of various diseases such as diabetes(糖尿病), hepatitis (肝炎), rheumatics (风湿), osteoporosis (骨质疏松) and senile dementia (老年性痴呆). 2 out of the 15 TCM-formulated drugs under development are Category-I drugs, i.e. drugs which have not previously been marketed in the PRC and/or worldwide.

this one look like gaining momemtum too. interest is flowing in

chinsoonyuen wrote: this one look like gaining momemtum too. interest is flowing in

I'm waiting for 2Q result to be out soon. If it confirms turning around, i don't mind to buy at higher price. Should have bought some more at 4.2-4.5c earlier

wonder anybody here has any new findings to share on Starpharm?

I am surprised!